ImmunoViroTherapy Lab

The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Business Finland.

Twitter and News

@vincersurf

New platforms are needed for pre-treatment testing of cancer therapies to avoid treating patients who are unlikely… twitter.com/i/web/status/1…

New #JITC article: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates mu… twitter.com/i/web/status/1…

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy 🧪… twitter.com/i/web/status/1…

New #JITC article: Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin @vincersurftwitter.com/i/web/status/1…